NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,075 | +0.8% | 10,552 | -0.1% | 0.44% | +6.7% |
| Q2 2023 | $1,066 | +9.4% | 10,561 | -0.2% | 0.42% | +0.5% |
| Q1 2023 | $974 | -49.1% | 10,587 | -49.8% | 0.42% | -3.5% |
| Q4 2022 | $1,914 | -99.8% | 21,092 | +99.5% | 0.43% | +11.1% |
| Q3 2022 | $804,000 | -9.8% | 10,572 | +0.3% | 0.39% | -4.7% |
| Q2 2022 | $891,000 | -4.9% | 10,542 | -1.2% | 0.41% | +12.5% |
| Q1 2022 | $937,000 | – | 10,674 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |